Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02688621 · ClinicalTrials.gov registry record · NA

Internet Assisted Obesity Treatment Enhanced With Financial Incentives

A NA study of Obesity, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
418
Enrollment target
2
Study locations

NCT02688621 is a NA study of Obesity that has completed, run by University of Vermont. The registered enrollment target is 418 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (49% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02688621, a NA study of Obesity, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
418 participants
Enrollment target
2
Study locations

Study Summary

The investigators propose a randomized controlled trial to evaluate whether the addition of financial incentives to a high-quality, online behavioral weight loss intervention produces better weight losses than the online treatment alone.

Conditions Studied

Interventions

  • BEHAVIORAL Internet Only
  • BEHAVIORAL Internet + Incentives

Study Locations (2)

South Carolina

  • University of South Carolina - Columbia

Vermont

  • Behavioral Weight Management Program/Univ of Vermont - Burlington

Trial Details

FieldValue
Enrollment Target 418 participants
Start Date 2016-04-11
Est. Completion 2019-08-02
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT02688621

The ClinicalTrials.gov registry entry for NCT02688621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 418 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (49% lower). The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Internet Only is the first listed.

NCT02688621 reports 2 study locations spanning 2 distinct geographic areas - top geographies include South Carolina, Vermont.

Frequently Asked Questions

What is clinical trial NCT02688621 about?

NCT02688621 is a clinical study titled "Internet Assisted Obesity Treatment Enhanced With Financial Incentives". The investigators propose a randomized controlled trial to evaluate whether the addition of financial incentives to a high-quality, online behavioral weight loss intervention produces better weight losses than the online treatment alone.

What is the current status of trial NCT02688621?

This trial is currently completed. It is a NA study. The enrollment target is 418 participants. The study started on 2016-04-11. Estimated completion is 2019-08-02.

What conditions does trial NCT02688621 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02688621?

The interventions under investigation include: Internet Only (BEHAVIORAL), Internet + Incentives (BEHAVIORAL).

Who is sponsoring clinical trial NCT02688621?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02688621 being conducted?

This trial has 2 study locations across South Carolina, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.